Shinoda et al. suggested that elevated concentrations of CCL2, CCL17, and CCL22 in BAL fluid may be predictive of poor outcome in patients with IPF, being associated with poor survival rate [32]. This evidence concerns the gene CCL22 and idiopathic pulmonary fibrosis.